Search filters

List of works by Mark A Boyd

A Randomized Study of Pharmacokinetics, Efficacy, and Safety of 2 Raltegravir Plus Atazanavir Strategies in ART-Treated Adults

article

A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy.

scientific article published on 15 April 2014

A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection.

scientific article

A randomized study to evaluate injection site reactions using three different enfuvirtide delivery mechanisms (the OPTIONS study).

scientific article published in January 2008

Addressing smoking among people living with HIV: a cross-sectional survey of Australian HIV health practitioners’ practices and attitudes

article

Ageing and long‐term CD4 cell count trends in HIV‐positive patients with 5 years or more combination antiretroviral therapy experience ⬇️

scientific article published on October 4, 2012

Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study

scientific article published on 26 June 2016

Antiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: a review of the recent literature

scientific article published on 13 December 2013

Antiretroviral roll-out: the problem of second-line therapy

scientific article published on July 2009

Antiretroviral therapy: dolutegravir sets SAIL(ING).

scientific article published on 3 July 2013

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines

scientific article published on July 2017

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018.

scientific article published in April 2018

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.

scientific article published on 20 January 2015

Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard fir

scientific article published in November 2016

Body composition substudy of the SECOND-LINE study - Author's reply.

scientific article published in June 2017

Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy

scientific article published on September 2013

Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapy

scientific article published in October 2014

Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).

scientific article published on January 2006

CD4(+) T Follicular Helper and IgA(+) B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals

scientific article

CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy

scientific article published on 14 March 2017

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study

scientific article published on 7 November 2017

Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz

scientific article published on 18 July 2006

Clinical Research in Low- and Middle-Income Countries ⬇️

scientific article published on July 1, 2009

Clinical management of treatment-experienced, HIV/AIDS patients in the combination antiretroviral therapy era.

scientific article published on January 2010

Co-infections in an HIV-infected man from Malawi.

scientific article published in January 2007

Combination ART: are two drugs as good as three?

scientific article published on 5 January 2018

Considering the benefits of disease-specific interventions on overall public health

scientific article published in May 2008

Creation of a drug fund for post-clinical trial access to antiretrovirals

scientific article published on 01 July 2004

Current and future management of treatment failure in low- and middle-income countries

scientific article published on January 2010

Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV.

scientific article published on May 2013

Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD).

scientific article published on 6 July 2009

Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy

scientific article published on May 2014

Dolutegravir—a promising antiretroviral in development ⬇️

scientific article published on October 20, 2011

Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens

scientific article published in March 2007

Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004–2015

article

Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapy.

scientific article

Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysi

scientific article published on 20 December 2017

Efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysis

scientific article published on 31 May 2016

Evidence and policy in the globalized response to AIDS

article

Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression

scientific article published in June 2009

HIV care in Yangon, Myanmar; successes, challenges and implications for policy.

scientific article

HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapy

scientific article published on 30 October 2013

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort

scientific article published in May 2004

Improvements in antiretroviral therapy outcomes over calendar time

scientific article published on May 2009

Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009.

scientific article published in November 2005

Indinavir: the forgotten HIV-protease inhibitor. Does it still have a role?

scientific article published on May 2007

Industry and bioethics: what price the relationship?

scientific article published on 27 June 2006

Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trial

scientific article published on 19 September 2011

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis

scientific article

Is it time to rethink syphilis control?

scientific article

Lack of enzyme-inducing effect of rifampicin on the pharmacokinetics of enfuvirtide

scientific article published in December 2003

Lack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patients

scientific article published in July 2004

Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trials

scientific article published on 16 June 2010

Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy ⬇️

scientific article published on November 7, 2012

Long-acting injectable ART: next revolution in HIV?

article

Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis

scientific article published in April 2006

Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial

scientific article published on 27 April 2017

Metastatic adenocarcinoma mimicking 'target sign' of cerebral tuberculosis

scientific article published in November 2006

Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trial

scientific article (publication date: 2014)

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

scientific article published on 19 March 2017

Novel antiretroviral agents and universal access to HIV care

scientific article

Operational research in HIV priority areas: the African way

article

Optimisation of HIV care and service delivery: doing more with less

scientific article published on 23 July 2012

Overly Optimistic Forecasts for the Impact of Treatment of HIV Prevention for Men Who Have Sex With Men

article

Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: a pilot study

scientific article published on 6 March 2012

Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients

scientific article published on 28 March 2003

Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects

scientific article published in October 2003

Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection

scientific article published in 2015

Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps

article

Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region

scientific article

Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience

article

Recent trends in early stage response to combination antiretroviral therapy in Australia

scientific article

Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir

scientific article published in May 2006

Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy

scientific article published in January 2018

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001 ⬇️

scientific article published on October 17, 2003

SPRING-2 the future of antiretroviral therapy

scientific article published on 25 September 2013

STRETCHing delivery of HIV health services

article

Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research

scientific article published on July 2007

Sexual transmission of HIV and the law: an Australian medical consensus statement.

scientific article published on November 2016

Smoking and HIV: what are the risks and what harm reduction strategies do we have at our disposal?

article

Tenofovir alafenamide: safer, but questions remain

scientific article

The LATTE study: a provocative brew

scientific article published on 17 July 2015

The Sydney Declaration: a call to scale up research

scientific article published in The Lancet

The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study

scientific article published on 4 August 2017

The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool

scientific article published in September 2011

The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa

scientific article published on 15 February 2013

The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity

scientific article published on 4 April 2006

Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke

scientific article published on 18 July 2017

Towards a universal second-line fixed-dose combination ART.

scientific article published on 5 October 2017

Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol

scientific article

Vaporised nicotine and tobacco harm reduction for addressing smoking among people living with HIV: A cross-sectional survey of Australian HIV health practitioners' attitudes.

scientific article published on 24 May 2017

Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012).

scientific article published on 25 September 2006

Which HIV patients should be screened for osteoporosis: an international perspective.

scientific article published on 18 February 2016

Paulina is supported by:

About Paulina

Help